{"disease":{"id":"hematopoietic-cell-proliferation","name":"hematopoietic cell proliferation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03107273","title":"Development of an in Vitro Hematopoietic Culture System and Application to Myelodysplastic Syndromes.","phase":"","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Centre Hospitalier Universitaire, Amiens","has_results":false},{"nct_id":"NCT04594031","title":"US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"ExCellThera inc.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}